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Summary.-Studies have been carried out into the effect usually referred to as
" repair ofpotentially lethal damage "following the treatment ofcells withbleomycin.
In vitro, increased survival was seen with delayed subculture of cells in bothexponen-
tial phase and plateau phase. It was unimportant whether the medium present
during the delay period had been previously used to support cell growth. Exposure
of cells growing as a solid tumour in vivo to bleomycin (4 mg/kg), gave a surviving
fraction of 2 x 10-3 if assay was carried out at 30 min but a surviving fraction of
virtually 100% if assay was delayed until 6 h.
Various possible artefacts have been eliminated as reasons for the observations
but doubts are raised regarding the nature of the mechanism involved.
AN EFFECTusually referredtoas "repair
of potentially lethal damage" (PLD)
following treatment of cells with bleomy-
cin (BLM) has been demonstrated both in
vitro (Ray et al., 1973; Barranco, Novak
and Humphrey, 1975) and in vivo (Hahn
et al., 1973; Twentyman and Bleehen,
1974; Takabe et al., 1974). After treat-
ment with BLM, delay in preparation of
a single cell suspension is associated with
a reduction in the killing effect seen when
trypsinization is carried out immediately
after exposure to BLM. In this paper
we report the results ofour further investi-
gations into this phenomenon.
AIATERIALS AND METHODS
Bleomycin was kindly supplied by
Lundbeck Ltd. The drug was dissolved in
sterile water and stored at -20°C. Immed-
iately before use the solution was thawed,
diluted in sterile Hanks' solution and either
added directly to the growth medium of
cells in vitro in a volume of between 0-05 and
0-2 ml or else injected into tumour bearing
mice. In most experiments, mice received
* Present ad(lress: MI.R.C. Clinical Oiicology and
Road, Cambridge.
the drug by the intraperitoneal route in a
volume of0-5 ml. When intravenous admin-
istration was required, a volume of 025 ml
was used.
The EMT6 cell line will grow either as a
monolayer in vitro or as a solid tumour in
mice of the BALB c strain (Rockwell, Kall-
man and Fajardo, 1972). In addition, assay
of cell survival following treatment in vivo
may be carried out by in vitro plating.
Our continuous culture subline EMT6/M/
CC and its growth conditions have been
described previously (Twentyman and
Bleehen, 1975; Twentyman et al., 1975).
Cultures were inoculated with 105 cells at
Day 0 and medium change was carried out
daily from Day 3. In this paper, exponential
phase cultures indicates cultures at Day 2,
early plateau phase refers to cultures at Day 5
or 6, and late plateau phase refers to cultures
at Days 15-18 after inoculation. Following
treatment with BLM, those cultures to be
trypsinized immediately were rinsedoncewith
minimal essential medium and then with
0075oo trypsin. Exposure to the enzyme for
15 min was used to remove the cells from
the plastic surface. Resuspension, counting,
dilution, plating and assay of surviving cells
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were carried out as previously described
(Twentyman and Bleehen, 1975). Where
trypsinization was to be delayed, a double
rinse with minimal medium was given and
the appropriate delay medium added to the
flask. If this medium had previously been
used for cell growth it was centrifuged for
10 min at 3000 rev/min and passed through a
0-2 Hum Millipore filter before use.
Cells to be treated with BLM in suspension
were trypsinized from a control flask immed-
iately before the experiment. After treat-
ment, thecellswerespundownat 1000rev/min
for 5 min, washed twice in fresh medium and
spun down each time, and thenfinallycounted
and diluted before plating.
Early experiments on the EMT6 solid
tumour were carried out on a subline desig-
nated EMT6/M/AC which has been fully
described by Watson (1975). Most of these
experiments, however, were carried out on a
different subline designated EMT6/VJ/AC,
kindly supplied by Dr E. Frindel, which
differs in its growth rate and morphological
characteristics. Experiments were carried
out between 10 and 13 days after inoculation
of 4 x 104 cells (corresponding to a tumour
size of 200 mm3). Groups of 3 tumours were
used except where otherwise stated.
Solid tumours were excised and single
cell suspensions were produced as previously
described (Twentyman and Bleehen, 1974).
The method was modified in that, following
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20 min agitation of tumour fragments in
Hanks' solution with added trypsin, 5 ml of
complete medium was added in order to
inactivate the trypsin. Centrifugation was
then carried out at room temperature. In
experiments designed to examine the repair
of PLD in solid tumours maintained in vitro,
the tumours were divided into pieces immed-
iately after excision. Those pieces intended
for delayed disaggregation were placed into
universal containers containing 5 ml of com-
plete medium and then maintained at either
37°C or kept on melting ice for the appropri-
ate period.
Where single cellsuspensionswererequired
without the use of trypsin, the chopped
tumour was agitated in Hanks' solution for
5 min at 37°C and then filtered through fine
wire gauze. This resulted in a suspension
with a low viability based on trypan blue
staining (20-30%) but a good yield of single
tumour cells.
Tumour growth experiments were carried
out by the intradermal inoculation of the
appropriate number oftumour cells in 0 05 ml
of Hanks' solution and subsequent caliper
measurements.
RESULTS
In vitro
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FIG. 1. Change in surviving fraction of cells treated with BLM in vitro for 1 h with period of delayed
subculture following drug exposure. Numbers against the curves indicate doses of BLM in pig/ml.
Error bars indicate m 2 s.e. based on the total colony count on 4 replicate dishes.
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but before trypsinization and subculture
is shown in Fig. 1. It may be seen that
this results in a considerable increase in
surviving fraction at all phases of growth.
The exponential phase cultures in these
experiments contained between 4 x 105 and
8 x 105 cells per flask at the time of the
experiment. In order to determine whether
the same increase in survival could be
demonstrated at much lower cell density,
one experiment was carried out in which
flasks were inoculated with 5 x 103 cells
at 3 days before the experiment and con-
tained about 6 x 104 cells at the time of
the experiment. The dose of BLM used
was 80 ,ag/ml for 1 h and surviving fraction
values obtained were 0 078 for immediate
subculture; 04187 for 90 min delay and
0-292 for 3 h delay in subculture. It is
clear, therefore, that enhanced surviving
fraction still occurs even in low density
exponential cultures.
Effect of cell/cell contact
Even when flasks contained only
6 x l_04 cells on Day 3 there was con-
siderable cell/cell contact as the culture
consisted of "colonies" of 8-1.6 cells. We
therefore carried out 2 experiments in
which cells were trypsinized from an early
plateau phase culture and re-inoculated
into new flasks at 105 cells/flask. After
TABLE I. Effect of 2 h Trypsinization
Delay on Cells Replated 3 h before BLM
Exposure in vitro
Surviving fraction Surviving fraction
(immediate (2 h trypsinization
Experiment trypsinization) delay)
A 0 106 (±0 032) 0 25 (±0 05)
B 0 059 (±0 024) 0-24 (+0 05)
Cell concentration= 105/flask. Errors shown
are ± 2 standard errors based on the total colony
count in groups of 4 replicate plates.
3 h in which the cells became attached to
the plastic surface, the experiments were
carried out in the usual manner. The
results are shown in Table I. It may be
seen that considerably enhanced survival
is brought about by delayed trypsiniza-
tion, even when the culture consists solely
ofsingle cells on the plastic surface.
Effect of mediam
It seemed possible that the medium
used for the delay period was an important
factor. A series ofexperiments was there-
fore carried outinwhich, followingremoval
ofBLM, the cells were incubated in growth
medium previously removed from growing
cultures. A typical set ofresults is shown
in Table II. It may be seen that the
extent of the increase in survival is not
dependent upon the medium used during
the delay period.
TABLE II The Effect of Medium Present during 2 h Delayed Subculture on Increacse
in Surviving Fraction of Cells Treated with BLM in vitro
Cell phase of growth BLM dose (,ug/ml) Source of delay medium Surviving fraction
Exponential 50 No delay 0-26 (±0 02)
(i.e. immediate
subculture)
Exponential 0 40 (±i0 03)
phase
Early plateau 0 42 (±O 03)
phase
Early
plateau
120 No delay
Exponential
phase
Early plateau
phase
Fresh medium
0-22 (4-0.02)
0-41 (±0-03)
0 43 (±0 03)
0 43 (±0 03)
Late 25 No delay 0-38 (±0 02)
plateau Late plateau 0 63 (±0 02)
phase
Fresh medlium 0 66 (±0* 02)
Errors shown are ± 2 standard errors based on the total colony count on grouips of 4 replicate plates.
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TABLE III.-Effect of Temperature on Increase in Surviving Fraction with 2 h Delayed
Subculture on Exponential Phase Cells Treated with BLM in vitro
Temperature at
which cells are held
for 30 min subsequent
to trypsinization and
resuspension
370C
220C
OO°C
370C
370C
37°C
Temperature at which
cells are held for first
30 min following removal
of BLM
370C
220C
OC
Errors shown are ± 2 standard errors based on the total colony count on groups of 4replicate plates.
Effect of temperature
Following trypsinization and resus-
pension of cells, there was usually a period
of 15-30 min during which the cells were
at room temperature while counting
occurred, dilutions were made, plating
carried out and the dishes placed in an
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incubator. For cells with delayed sub-
culture, however, a temperature of 37°C
was maintained, as the medium used for
rinsing and during the delay period was
kept at 37°C until just before use. We
therefore investigated whether the drop
in temperature could be responsible for
the lower survival with immediate sub-
culture. Cells from flasks trypsinized
immediately after drug exposure were,
after resuspension, divided into 3 aliquots
and kept either at 37°C or 22°C or 0°C
for the 30 min during counting, dilution
and plating, before being returned to the
incubator in the cloning dishes. Flasks
for delayed trypsinization were, after
medium change, kept at 37°C, 22°C or
0°C for 30 min, before being returned to
the incubator for the remaining 90 min
delay period. The results for exponential
phase cells exposed to BLM (50 ,ug/ml)
for 1 h, with 2 h delayed subculture where
appropriate, are shown in Table III. It
is seen that no effect oftemperature change
could be detected. The results for early
and late plateau phase cells obtained in
similar experiments led to the same
conclusion.
, ,1 4 , -j In vivo
2 4 6 8 16 24 Time response
Time after BLM. (h) The surviving fraction of cells taken
2.-Change in surviving fraction of cells from EMT6 solid tumours at different posed to BLM in vivo with time of times after the administration of BLM
mour removal after drug administration.
uares indicate intravenous drug admin- (4 mg/kg) to the hosts is shown in Fig. 2.
ration, circles indicate intraperitoneal This dose was chosen as appropriate on
ministration. Closed symbols are for the basis of our previous studies on this mour subline EMT6/VJ/AC. Open circles
3 for subline EMT6/M/AC. tumour at various sizes (Twentyman and
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Bleehen, 1974). It may be seen that, for
intraperitoneal administration, the mean
survival is about 0.30o at 30 min, rises
rapidly to about 100% at 2 h and to nearly
100% by 6 h. When the drug was admin-
istered by the intravenous route, the
surviving fraction had reached a minimum
by 10 min. Little change occurred
between 10 and 30 min but then a con-
siderable increase was seen between 30 min
and 1 h, thus agreeing with the results
for intraperitoneal administration.
These results cannot be explained on
the basis of either selective loss of dead
cells from the tumour or preferential
proliferation of survivors. The cell yield
from tumours of equal size was approxi-
mately the same in animals treated 30 min
or 6 h previously with BLM as it was in
control animals, and 6 h is too short a time
for post-treatment proliferation to have
become a significant factor.
Drug carry-over
In order to determine whether cells
taken at short times after BLM were
liable to carry a significant amount of
drug over into the medium in colony
dishes we calculated the amount. A dose
of 4 mg/kg is approximately equal to 041
mg/mouse. If, in the extreme case, all
this goes to the tumour (mass about 100
mg) which contains about 6 x 107 cells,
then the amount of BLM in 300 cells
plated 100 X (300,ug)/(6 x 10-7)which
approximately equals 5 x 10-4 ,ug. This
is several orders of magnitude lower
than the level generally considered to be
cytotoxic to EMT6 cells in vitro (Bleehen,
Gillies and Twentyman, 1974). In 2
experiments, we plated out untreated
control cells with a large number of cells
taken from tumours excised 30 min after
BLM administration. The colony count
in these plates was approximately equal
to the sum of the counts found in the
control plates and in the plates containing
treated cells. This indicates that any
drug released from treated cells after
plating was insufficient to kill untreated
cells in the same dishes. Furthermore,
we found that the number of colonies per
cell plated was approximately constant
for treated cells over a factor of 100 in
number of cells plated. If drug release
were a significant factor, it would be
expected that the ratio would decrease
with increasing number of cells plated and
hence amount of drug carried over.
Effect of trypsin
Two experiments were carried out to
measure the surviving fraction at 30 min
after BLM in which suspensions were
prepared both with and without the use of
trypsin. Without trypsin, the cell yield
was relatively low, the viability was
relatively low (20-40%) and some small
clumps of cells were seen. The results
are shown in Table IV. It may be seen
that the surviving fraction is similar for
both methods of cell preparation, bearing
in mind the usual variation between
individual determinations.
Effect of temperature
During the removal of tumours from
animals, preparation ofthe cellsuspension,
TABLE IV. Effect ofTrypsin on Measured Surviving Fraction Following BLM (4 mg/kg)
for 30 min in vivo
Experiment Treatment ± Trypsin Plating efficiency % Surviving fraction
A Control + 47 1L0
Control 29 1.0
BLM 30 min + - 0*0058 (+O 0008)
BLM 30 min - 0 0037 (±O 0003)
B Control + 52 1*0
Control 39 1 0
BLM 30 min + - 0O 0020 (±O 0004)
BLM 30 min 0 0036 (±0 0005)
Errors shown are ± 2 standard errors based on the total colony count on groups of 4 replicate plates.
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counting, diluting and plating, the cells
are cooled to room temperature. Cells
left in the animal, however, remain at
370C. An experiment was therefore
carried out in which the entire procedure
was carried out both in the normal way
and also in a warm room set at 370C. The
results are shown in Table V. It may be
seen that the results follow the same
pattern for both sets of experimental
conditions.
TABLE V.-Effect of Temperature on
Measured Surviving Fraction Following
BLM (4 mg/kg) in vivo
Temperature at Surviving fraction
which experiment , A
carried out 1 h after BLM 2 h after BLM
220C 0 0051 (±0*0011) 0*119 (±0*012)
370C 0 0088 (±0 0014) 0 197 (+0.017)
Errors shown are ± 2 standard errors based on
the total colony count on groups of4replicateplates.
Delay in vitro
The effects of keeping either pieces of
solid tumour or a cell suspension at either
370C or 00C in medium in vitro after
removal of the tumour at 30 min after
BLM are shown in Fig. 3. All surviving
fractions for cells plated immediately
after tumour removal and trypsinization
have beennormalized to anarbitrary value
"S". The actual surviving fraction lay
between 0-002 and 0-02 in the various
experiments' It can be seen that when
pieces of solid tumour are kept at 370C
there is a considerable increase insurviving
fraction over a period of 4 h, by about a
factor of 10. At 00C, however, no increase
occurs. If, on theotherhand, thetumours
are converted to cell suspension before
being reincubated, increase in surviving
fraction does not occur either at 370C or
0°C. A further set of experiments was
carried out in which tumour pieces were
placed firstly for 2 h at 00C and then for
4 h at 370C. If, once again, the surviving
fraction for immediate trypsinization is
normalized to "S"then thevaluesobtained
were 9-6, 1240 and 3-6 times "S" in 3
separate determinations. It therefore
105 'S
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FIG. 3.-Change in surviving fraction of cells
exposed in vivo to BLM for 30 min with
length of subsequent holding in vitro before
plating out. Circles refer to holding as
tumour pieces. Triangles refer to holding
as cell suspension. Solid symbols refer to
holding at 37°C. Open symbols refer to
holding at 0°C. Error bars indicate ± 2
s.e. based on the total colony count on 4
replicate dishes.
appears that the ability to increase sur-
viving fraction may be "stored" at 00C.
Inoculation of new tumours
To ensure that the large difference in
surviving fraction between cells cloned
shortly after exposure to BLM and cells
taken at later times is not an artefact
of the cell culture procedure, we looked at
the growth of tumours in mice given cells
taken from treated animals. The growth
of tumours in groups of 10 recipient mice
are shown in Fig. 4. The solid lines are
drawn through the mean tumour volumes
of mice given 4 x 104 or 103 cells from
untreated tumours at Day 0. The solid
circles show the mean tumour volumes
of mice given 4 x 104 or 103 cells from
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FIG. 4. Growth of tumours with time after inoculation. Solid lines are mean growth curves for
inoculation of 4 x 104 and 103 untreated cells. Closed circles, meantumourvolumes forinoculation
of 4 x 104 and 103 untreated cells and administration of BLM (10 mg/kg) to recipient mice 3 days
later. Open circles, mean tumour volumes for inoculation of 4 x 104 cells taken from donor mice
treated 24 h previously with BLM (10 mg/kg) Open squares, mean tumour volumes for inoculation
of 4 x 104 cells taken from donor mice treated 1 h previously with BLM (10 mg/kg). Error bars
represent + 2 s.e. of the mean.
untreated tumours at Day 0 and then a
single intraperitoneal injection of BLM
(10 mg/kg) 3 days later. It may be seen
that this treatment had little effect on
the growth of the tumours for either size
of inoculum. The open circles show the
mean tumour volume for mice receiving
4 X 104 cells at Day 0 taken from mice
whose tumours had been treatedwith BLM
(10 mg/kg) 24 h previously. Again, there
is no significant difference between these
points and the points for an equal number
of cells taken from untreated tumours.
The open squares show the mean tumour
volume for mice receiving 4 x 104 cells
at Day 0 taken from mice whose tumours
had been treated with BLM (10 mg/kg)
one hour previously. In this case, the
mean tumour volume is for the 4 tumour
takes in a group of 10 recipients. Six
recipients of this inoculum remained
tumour-freeforaperiodof30daysandhave
been excluded from the mean. It is clear
that in this case a very marked reduction
in the ability of the cells to grow new
tumours had occurred, thereby confirming
the effect seen in the cell culture studies.
In vitro sensitivity of cells from tumours
The survival of cells taken from solid
tumours at 30 min after BLM was much
lower than may have been expected
from any of our in vitro data. We there-
fore attempted to establish a basis for
comparison by treating in suspension,
after trypinization, cells taken either
from solid tumours or from late plateau
phase cultures. The results are shown
in Fig. 5. For late plateau phase cells
the dose-response curve is little different
whether the cells are treated on the flask
surface before trypsinization or in sus-
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FIG. 5. Change in surviving fraction of cells
wi'th dose of BLM during 30min drug expos-
ure. Closed circles, late plateau phase cells
in vitro treated as a monolayer before tryp-
sinization. Open circles, late plateau phase
cells in vitro treated in suspension after
trypsinization. Squares, cells taken from
tumours treated in suspension after tryp-
sinization. Error bars indicate +2 s.e.
based on the total colony count in groups
of 4 replicate plates.
pension immediately after trypsinization.
If cells from solid tumours were treated
in suspension for 30 min after trypsiniz-
ation and resuspension, the surviving
fraction was about 5% at a dose of 50-
100 ,ug/ml. It is clear that even if there
was a considerable concentration of drug
into the tumour this result cannot explain
the in vivo results of about 0.2% for a
dose of 4 mg/kg either intraperitoneally or
intravenously given 30 min before tumour
excision.
DISCUSSION
It is well established that the survival
of mammalian cells following treatment
with ionizing radiation may be modified
by changingthepost-irradiation conditions
to which the cells are exposed. For
instance, exposure to cyclohexamide
(Phillips and Tolrnach, 1.966), exposure
to low temperature (Whitmore andGulyas,
1967) and incubation in a balanced salt
solution (Belli and Shelton, 1969) have
all been found to increase the surviving
fraction if applied after irradiation. On
the other hand, Phillips and Tolmach
(1966) have found that post-irradiation
treatment with inhibitors of DNA syn-
thesis or exposure to 29°C cause a decrease
in surviving fraction. The term "poten-
tially lethal damage" has been used by
Phillips and Tolmach (1966) to refer to
damage which may be repaired under
some circumstances but which is able to
lead to cell death given certain post-irrad-
iation conditions which by themselves
have no effect on the survival of control
cells.
Hahn and Little (1972) pointed out
that conditions leading to increased
survival following irradiation were those
associated with a slowing down of the
normal progression of cells through their
life cycle. These workers then went on
to examine the relative ability to repair
radiation induced PLD of cells in the
exponential and plateau phases ofgrowth.
In exponential phase, where the cells are
almost all in a rapid state of proliferation,
the radiation survival was the same
whetherthe cells were subcultured immed-
iately after irradiation or leftintheoriginal
monolayer for several hours before sub-
culture. On the other hand, crowded
cultures in the plateau phase, where the
amount ofproliferation is greatly reduced,
showed a considerable increaseinsurviving
fraction ifallowed toremaininthecrowded
state following irradiation than if immed-
iately subcultured. Hahn and Little
(1972) attributed this finding to the fact
that cells in crowded cultures had more
time to repair PLD before fixation of
damage had occurred. The amount of
PLD was greater at lower survival levels
and this led to a reduction in the slope of
the survival curve.
Subsequently, Little et al. (1973) were
able to demonstrate a similar effect in
vivo either in a crowded ascites tumour or a
solid tumour in the mouse. The effect
could not, however, be seen in the ascites
tumour during exponential growth.
Repair of PLD following drug treat-
ment has been investigated in vitro by
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Ray et al. (1973). In this study repair
of PLD occurred in both exponential and
plateau phase cells folowing treatment
with 5-FU, but only in plateau phase
following treatment with bleomycin.
Subsequently, however, using a different
cell line, Barranco et al. (1975) showed
repair of PLD following bleomycin treat-
ment both in exponential and plateau
phases. In vivo, Hahn etal. (1973) showed
repair ofPLD in the EMT6 mouse tumour
following treatment with cyclophos-
phamide, 5-fluorouracil and bleomycin.
We were able to confirm that BLM damage
is repaired in solid EMT6 tumours over
a wide range of sizes (Twentyman and
Bleehen, 1974).
The studies described in the present
paper add information on several aspects
of this problem. We find that cells are
able to repair PLD in exponential, early
and late plateau phases, and to approxi-
mately the same extent from the same
surviving fraction. Thus, the rate of
proliferation of the treated cells does not,
in our work, appear to be a crucial factor.
Furthermore, the source of medium used
during the subculture delay period does
not seem to be an important factor,
although our previous studies have shown
(Twentyman et at., 1975) that medium
from plateau cultures is less abletosupport
cellgrowththanexponentialphasemedium.
This is in contrast to the finding by Little
(1971) that conditioned medium can
enhance the repair of PLD in irradiated
cells. We have also shown that when
cells are re-inoculated into flasks shortly
before the experiment, PLD repair still
occurs, thus ruling out local cell crowding
as a factor. In addition, the possibility
of an artefact due to temperature changes
during subculture has been ruled out.
Our results in vivo show that the
effect of PLD repair can be very much
greater than has previouslybeendescribed.
Whereas Hahn et al. (1973) showed a
recovery from about 10% to 70% sur-
vival between 2 and 24 h after relatively
low BLM doses, we have found a recovery
from about 0.2% to 90% between 30 min
and 6 h, i.e. a factor of about 500 times.
Again, we have ruled out temperature
variations and the use of the enzyme,
trypsin, during subculture as possible
artefacts. We have also shown that
PLD repair occurs in tumour pieces held
in vitro for 4-6 h at 37°C after excision,
does not occur at OC but may be stored
at 0°C for later expression at 37°C.
It is extremely difficult to formulate
any explanation which encompasses all
the effects which we have observed.
Having shown that both exponential
and plateau phase cells repair PLD in
vitro, we are left to discover what there
is about the subculturing procedure which
modifies survival, both in vitro and in vivo.
There are several points which need to be
made. Firstly, it has b-een shown by
Barranco and Humphrey (1971) that, in
addition to killing cells, BLM also induces
a progression delay in the cell cycle.
This delay could possibly allow repair of
BLM lesions which would have been lethal
if progression had continued unaltered.
It would, however, be necessary to also
show that the subculturing procedure was
able to remove the progression delay,
whilst medium change was not. We
know of no evidence to support this.
Studies by Schiaffini (unpublished data)
have shown that repair of PLD following
BLM treatment of Chinese hamster cells
in vitro follows the same time course as re-
joining of DNA strand breaks induced by
BLM, with possible implications regarding
the nature of the repair processes. Auto-
radiographic work by Fujimoto (1974)
has shown that if 14C labelled BLM is
administered to mice bearing an ascites
tumour, then the label is almost all at the
cell surface at 2 h, has passed to the nuc-
lear membrane by 4 h and visible necrosis
sets in between 4 and 8h. Thismayimply
that BLMexerts alethaleffect on cells only
ifallowed a considerable period of time to
enter the cell, having initially become
absorbed on to the cell membrane. For
this to explain the PLD story would
require that some aspect of the subcult-
uring procedure increased the rate of
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entry of BLM into the cell. Having
ruled out the use of trypsin as the vital
factor, at least in vivo, one is left with the
possibility that any procedure, including
mechanical disaggregation, is sufficiently
traumatic that the membrane is damaged.
Another factor which requires explan-
ation is the apparent discrepancy between
the in vivo sensitivity if measured at
30 min and the in vitro sensitivity. One
possible explanation is that the cell mem-
brane is much more permeable to BLM
when in the in vivo environment and
that this permeability is lost when the
tumour is made into a cell suspension
and then exposed to the drug. It seems
unlikely, however, that exposure to tryp-
sin could cause this loss of permeability
because the sensitivity of in vitro cells is
similar when exposed to BLM either
before or after trypsinization. An
alternative explanation is that BLM is
converted in vivo to a more active form.
It does appear, however, that permeability
of the cell membrane is a very important
factor in determining the sensitivity of cells
to BLM. It has been shown that the
action of the antifungal polyene, penta-
mycin, which increases membrane per-
meability, can markedly increase the
ability of BLM to inhibit DNA and RNA
synthesis in cells (Nakashima et al., 1974).
Our own unpublished studies with penta-
mycin indicate that its use can increase
by 100-fold the cell killing effect of BLM.
The balance of available evidence
would therefore indicate that some aspect
of the subculture procedure, as yet
undetermined, either allows more BLM
to enter the cell or else inhibits the repair
of BLM damage. If the former explan-
ation is the correct one, it may be that
the phenomenon of PLD repair is really
only an artefact induced by the procedure
of making cell suspensions and has no
significance with regard to cellular repair
mechanisms. It would, however, leave
open the possibility that manipulation of
membrane permeability by other agents
could be used to increase the efficacy of
BLM. If, on the other hand, PLD repair
does involve intracellular repair processes,
then the possibility arises that BLM
effectiveness could be increased by the
combined use with agents known to act,
in one way or another, as inhibitors of
various types of repair. We are currently
investigating these possibilities.
In this discussion, we have used the
expression "repair of potentially lethal
damage" in accordance with the usage
which has become common over the last
few years. At our present state of know-
ledge, however, it is in many ways an
unfortunate expression in that it carries
possible implications regarding mechan-
isms that are generally unjustified. In
the absence of specific information
regarding the nature of the damage
sustained by cells, and evidence that
repair of such damage is responsible for
the increased survival with delayed tryp-
sinization, great caution must beexercised.
Furthermore, whilst increased survival
with delayed trypsinization may be
observed following exposure to both
drugs and to x-rays, there is no necessity
that the same mechanism be involved in
both instances.
It is very clear from our results that
in a situation where a tumour is treated
in vivo and subsequently assayed in vitro,
the result obtained can be extremely
dependent upon the time after treatment
at which the tumour is excised. It would
appear therefore that any investigation
of tumour response based on this type
of assay should always include a careful
investigation of the significance of this
factor.
We thank Miss Stella Keller for her
excellent technical assistance.
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